Cargando…

Prophylaxis of Malaria

Malaria prevention in travelers to endemic areas remains dependent principally on chemoprophylaxis. Although malaria chemoprophylaxis refers to all malaria species, a distinction should be drawn between falciparum malaria prophylaxis and the prophylaxis of the relapsing malaria species (vivax &...

Descripción completa

Detalles Bibliográficos
Autor principal: Schwartz, Eli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395692/
https://www.ncbi.nlm.nih.gov/pubmed/22811794
http://dx.doi.org/10.4084/MJHID.2012.45
_version_ 1782238019409936384
author Schwartz, Eli
author_facet Schwartz, Eli
author_sort Schwartz, Eli
collection PubMed
description Malaria prevention in travelers to endemic areas remains dependent principally on chemoprophylaxis. Although malaria chemoprophylaxis refers to all malaria species, a distinction should be drawn between falciparum malaria prophylaxis and the prophylaxis of the relapsing malaria species (vivax & ovale). While the emergence of drug resistant strains, as well as the costs and adverse reactions to medications, complicate falciparum prophylaxis use, there are virtually no drugs available for vivax prophylaxis, beside of primaquine. Based on traveler’s malaria data, a revised recommendation for using chemoprophylaxis in low risk areas should be considered.
format Online
Article
Text
id pubmed-3395692
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Università Cattolica del Sacro Cuore
record_format MEDLINE/PubMed
spelling pubmed-33956922012-07-18 Prophylaxis of Malaria Schwartz, Eli Mediterr J Hematol Infect Dis Reveiw Articles Malaria prevention in travelers to endemic areas remains dependent principally on chemoprophylaxis. Although malaria chemoprophylaxis refers to all malaria species, a distinction should be drawn between falciparum malaria prophylaxis and the prophylaxis of the relapsing malaria species (vivax & ovale). While the emergence of drug resistant strains, as well as the costs and adverse reactions to medications, complicate falciparum prophylaxis use, there are virtually no drugs available for vivax prophylaxis, beside of primaquine. Based on traveler’s malaria data, a revised recommendation for using chemoprophylaxis in low risk areas should be considered. Università Cattolica del Sacro Cuore 2012-06-29 /pmc/articles/PMC3395692/ /pubmed/22811794 http://dx.doi.org/10.4084/MJHID.2012.45 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reveiw Articles
Schwartz, Eli
Prophylaxis of Malaria
title Prophylaxis of Malaria
title_full Prophylaxis of Malaria
title_fullStr Prophylaxis of Malaria
title_full_unstemmed Prophylaxis of Malaria
title_short Prophylaxis of Malaria
title_sort prophylaxis of malaria
topic Reveiw Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395692/
https://www.ncbi.nlm.nih.gov/pubmed/22811794
http://dx.doi.org/10.4084/MJHID.2012.45
work_keys_str_mv AT schwartzeli prophylaxisofmalaria